Edition:
United Kingdom

Conmed Corp (CNMD.OQ)

CNMD.OQ on NASDAQ Stock Exchange Global Select Market

67.38USD
16 Jan 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$67.38
Open
$65.80
Day's High
$67.44
Day's Low
$65.80
Volume
102,259
Avg. Vol
68,975
52-wk High
$82.95
52-wk Low
$55.56

Latest Key Developments (Source: Significant Developments)

Conmed announces definitive agreement to acquire Buffalo Filter Llc
Thursday, 13 Dec 2018 

Dec 13 (Reuters) - Conmed Corp ::CONMED ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE BUFFALO FILTER LLC.CONMED ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE BUFFALO FILTER LLC.CONMED CORP - DEAL FOR $365 MILLION ON A CASH-FREE, DEBT-FREE BASIS..CONMED CORP - TRANSACTION IS EXPECTED TO BE FINANCED THROUGH A COMBINATION OF NEW CONVERTIBLE NOTES AND EXPANDED AND AMENDED CREDIT FACILITY.CONMED CORP -.CONMED CORP - BASED ON ANTICIPATED DATE OF CLOSING, CONMED EXPECTS ACQUISITION TO BE NEUTRAL TO ADJUSTED CASH EARNINGS PER SHARE IN 2019.CONMED CORP - ACQUISITION SEEN IMPROVING PROFITABILITY PROFILE BY ADDING ABOUT 50 BASIS POINTS TO ORGANIC CONSTANT CURRENCY REVENUE GROWTH.CONMED CORP - ON A GAAP BASIS, TRANSACTION IS EXPECTED TO BE DILUTIVE IN 2019, AND LESS DILUTIVE OR INCREASINGLY ACCRETIVE THEREAFTER.CONMED - BASED ON CLOSING, EXPECTS ACQUISITION TO BE BETWEEN $0.10 AND $0.15 PER SHARE ACCRETIVE TO ADJUSTED CASH EARNINGS PER SHARE IN 2020.  Full Article

Conmed Q3 GAAP Earnings Per Share $0.20
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Conmed Corp ::ORATION ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 GAAP EARNINGS PER SHARE $0.20.Q3 ADJUSTED EARNINGS PER SHARE $0.46.Q3 SALES $202.3 MILLION VERSUS I/B/E/S VIEW $198.5 MILLION.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $2.15 TO $2.20.Q3 EARNINGS PER SHARE VIEW $0.46 -- THOMSON REUTERS I/B/E/S.COMPANY RAISES ITS FULL-YEAR 2018 SALES GUIDANCE..SEES FULL-YEAR 2018 CONSTANT-CURRENCY AND AS ADJUSTED SALES GROWTH IN RANGE OF 6.5% TO 7%.  Full Article

Conmed Corp Reports Q2 Adjusted Earnings Per Share $0.46
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Conmed Corp ::ORATION ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.46.Q2 GAAP EARNINGS PER SHARE $0.30.Q2 SALES $212.8 MILLION VERSUS I/B/E/S VIEW $207.1 MILLION.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $2.15 TO $2.20.Q2 EARNINGS PER SHARE VIEW $0.45 -- THOMSON REUTERS I/B/E/S.CONMED - RAISING ITS PREVIOUSLY ISSUED CONSTANT-CURRENCY 2018 SALES GUIDANCE.EXPECTS FULL-YEAR 2018 CONSTANT-CURRENCY SALES GROWTH IN RANGE OF 6% TO 7%.  Full Article

Conmed Corp announces retirement of CFO ‍Luke A. Pomilio
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Conmed Corp :Conmed Corp announces retirement of chief financial officer.Conmed Corp - ‍Luke A. Pomilio, executive vice president, finance and chief financial officer, has decided to retire​.Conmed Corp - ‍company has initiated a search for a new CFO​.  Full Article

Conmed Corp reports Q3 adjusted earnings per share $0.42
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Conmed Corp :Conmed Corp announces third quarter 2017 financial results.Q3 adjusted earnings per share $0.42.Q3 sales $190.1 million versus I/B/E/S view $187.1 million.Q3 earnings per share view $0.41 -- Thomson Reuters I/B/E/S.Q3 GAAP earnings per share $0.26.Conmed Corp - ‍expects 2017 constant currency sales growth in range of 2.50% to 3.25%​.Conmed Corp - ‍expects 2017 adjusted diluted net earnings per share in range of $1.85 to $1.90​.Fy2017 earnings per share view $1.87, revenue view $780.4 million -- Thomson Reuters I/B/E/S.  Full Article

Conmed Corporation Q2 earnings per share $0.22
Wednesday, 26 Jul 2017 

July 26 (Reuters) - Conmed Corp :Conmed Corporation announces second quarter 2017 financial results.Q2 adjusted earnings per share $0.41.Q2 GAAP earnings per share $0.22.Q2 sales $197.2 million versus I/B/E/S view $194.5 million.Q2 earnings per share view $0.41 -- Thomson Reuters I/B/E/S.Conmed Corp - company now expects 2017 constant currency sales growth in range of 2% to 3%.Conmed Corp - company continues to expect FY 2017 adjusted diluted net earnings per share in range of $1.85 to $1.95.  Full Article

Lexion Medical says a jury found unit of CONMED Corp liable for false advertising
Thursday, 13 Apr 2017 

Lexion Medical LLC: Jury awards $10 million in punitive damages against SurgiQuest, a subsidiary of CONMED Corporation for false advertising in dispute with Lexion Medical .Jury awarded $2.2 million in lost profit damages and $10 million in punitive damages against SurgiQuest, unit of CONMED Corp.  Full Article